Form 4: Nurix Therapeutics Director Sells Shares
Insider Transaction (Form 4)
Julia P Gregory, a Director of Nurix Therapeutics, Inc., sold 22,583 shares of common stock on October 14, 2026 for $23.40 per share.
Summary
- Option exercise/conversion: acquired 22,583 Common Stock at $1.86 ($42,004) on October 14, 2026; holds 33,333 after (Direct).
- Open-market sale: disposed of 22,583 Common Stock at $23.40 ($528,528) on October 14, 2026; holds 10,750 after (Direct).
- Option exercise/conversion: disposed of 22,583 Director Stock Option (right to buy) on October 14, 2026 (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $528,528 of stock on the open market.
Insider Transactions
Julia P Gregory — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-10-14 | Option exercise/conversion | Common Stock | 22,583 | $2 | $42.0K | 33,333 |
| 2026-10-14 | Open-market sale | Common Stock | 22,583 | $23 | $528.5K | 10,750 |
| 2026-10-14 | Option exercise/conversion | Director Stock Option (right to buy) | 22,583 | — | — | 0 |
Key Dates
| Date | Description |
|---|---|
| 2026-10-14 | Option exercise/conversion (22,583 shares) |
| 2026-10-14 | Open-market sale (22,583 shares) |
| 2026-10-14 | Option exercise/conversion (22,583 shares) |
Keywords
insider transaction, Form 4, NRIX, Nurix Therapeutics, Inc., bearish, Julia P Gregory
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.